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Background: Limited data suggest that the hemodynamic severity of non-culprit
vessel (NCV) stenoses in the setting of STEMI can reliably be assessed by FFR.
However, there is uncertainty about the stability of this measurement over time,
resulting from difﬁculties in achieving maximal hyperemia in non infarct territories.
We evaluated the stability of FFR of NCV stenoses over a period of 45 days following
STEMI.
Methods: At 2 centres, 47 STEMI patients who had percutaneous revascularization of
the infarct-related artery were prospectively enrolled in the FFR STABILITY study.
FFR was performed in 55 NCV stenoses with at least a 50% diameter stenosis by
visual angiographic assessment and minimum luminal diameter of 2.5 mm. Baseline
FFR was obtained immediately after successful revascularization of the culprit
stenosis and was repeated at 41.8  10.2 days. LVEF and quantitative coronary
angiography (QCA) were assessed by the angiographic core lab on baseline and
follow up angiograms.
Results: Mean FFR values for the NCV stenoses decreased between the acute
presentation and follow-up (0.84  0.08 vs. 0.82  0.08, respectively, p ¼ 0.025).
However, baseline FFR was highly correlated with follow-up (Pearsons coefﬁcient
R¼0.85, p<0.001) and in only 3 patients the FFR value was higher than 0.8 during
the index STEMI and lower than 0.8 at follow-up (see Figure).
Conclusions: FFR of NCV stenoses assessed during acute angiography for STEMI
remain relatively stable over the subsequent 45 days. An FFR obtained in the setting
of STEMI is likely a valid measurement to guide delayed revascularization decisions
in patients with MVD.
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Background: Recent randomized trials showed that FFR-guided revascularization is
safe and effective. However, long-term clinical outcomes of real world use of FFR,
including the decisions against FFR, have not been fully evaluated.
Methods: 1294 patients who underwent FFR measurement for de novo coronary
lesions were included. FFR measured lesions (n¼1628) were divided into FFR-defer
or FFR-stent lesions according to the treatment strategy selected after FFR
measurement.
Results: Mean FFR was 0.800.12 and FFR was 0.8 in 728 lesions (44.7%). Five-
year cumulative rate of all death was 6.3%, myocardial infarction, 1.5% and any
revascularization, 12.5%. Among 902 lesions with FFR>0.8, 208 lesions were stented
and there was no difference in 5-year target lesion related outcomes between deferred
and stented lesions (HR 1.783 95% CI 0.677-4.697, p¼0.242). Among 797 deferred
lesions, the determinant for the 1-year target lesion related events was the presence of
diabetes (HR 3.74, 95% CI: 1.45-9.67, p¼0.006) while the determinant for delayed
events (1-5years) was FFR<0.8 (HR 4.50, 95% CI: 1.65-12.28, p¼0.003). Angio-
graphic lesion severity was not an independent predictor for clinical events during
follow-up among deferred lesions.
Conclusions: Real world use of FFR in the DES era was associated with favorable
long-term patient- and lesion-related outcomes. Stenting or medical treatment against
FFR-guidance could not improve the outcomes.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-630
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Background: Patients with ST-segment elevation myocardial infarction (STEMI)
have an increased risk of incomplete stent apposition after drug-eluting stent
implantation. The vascular response was assessed after treatment with the third
generation biolimus-eluting Nobori stent with biodegradable polymer compared to the
ﬁrst generation permanent polymer sirolimus-eluting Cypher stent in patients with
STEMI treated with primary percutaneous coronary intervention.
Methods: In the Randomized Comparison of Biolimus-Eluting Biodegradable Poly-
mer Coated Stent and Durable Polymer Sirolimus-Eluting Stent in Unselected Patients
(SORT OUT V) trial, a formal intravascular ultrasound (IVUS) study enrolled 116
STEMI patients (57 biolimus-eluting stents and 59 sirolimus-eluting stents) treated
with primary percutaneous coronary intervention where post-procedure and 12-month
follow-up imaging data were available. The IVUS endpoint included in-stent percent
volume obstruction and incomplete stent apposition.
Results: Median stent length measured 18.7 mm (interquartile range 16.7 mm to 27.5
mm). In-stent percent volume obstruction did not differ between biolimus-eluting
stents and sirolimus-eluting stents [median (interquartile range): 1.8% (0.0% to 4.5%)
vs. 1.4% (0.0% to 7.2%) p¼ns]. Biolimus-eluting stent compared to sirolimus-eluting
stent did not reduce the frequency of acute incomplete stent apposition (15.8% vs.
22.0%, p¼ns), late incomplete stent apposition (26.3 vs. 27.1%, p¼ns) or late
acquired incomplete stent apposition (14.0% vs. 18.6%, p¼ns). One aneurysm
occurred at follow-up in a biolimus-eluting stent treated patient.
Conclusions: Compared to a sirolimus-eluting stents the biolimus-eluting Nobori
stents with a biodegradable polymer did not reduce neointimal hyperplasia or the
frequency of acute or late acquired incomplete stent apposition in STEMI patients.
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Background: Intravenous adenosine infusion (IV-Ado) produces coronary and
systemic vasodilatation generally leading to systemic hypotension. However, Ado-
induced hypotension during maximal coronary hyperemia is heterogeneous, and its
relevance for coronary stenoses assessment with fractional ﬂow reserve (FFR) remains
largely unknown.
Methods: FFR, coronary ﬂow reserve (CFR) and microcirculatory resistance (IMR)
were measured in 93 stenosed arteries (79 patients). Clinical and intracoronary
measurements were analyzed among tertiles of the percentage degree of Ado-induced
hypotension, deﬁned as: %DPa¼ -[100 - (hyperemic aortic BP x 100 /rest aortic BP)] .
Results: Overall, %DPa was -13.6  12.0%. Body mass index was associated with %
DPa (r¼0.258, p¼0.025) and obesity an independent predictor of profound Ado-
induced hypotension (tertile 3 of %DPa) [OR 3.95 (95% CI: 1.48, 10.54), p¼0.006]. %
DPa was associated with IMR (r¼ 0.311, p¼0.002), CFR (r¼ -0.246, p¼0.017) and
marginally with FFR (r¼ 0.203, p¼0.051). However, IMR (beta¼0.003, p<0.001) and
not %DPa (beta¼-0.001, p¼0.564) was independently associated with FFR. When
compared with tertiles 1 and 2 of %DPa [n¼62 (66.6%)], stenoses assessed during
profound Ado-induced hypotension [n¼31 (33.3%)] had lower IMR [12.4 (8.6-22.7) vs
20 (15.8-35.5); p¼0.001] and FFR values (0.77  0.13 vs 0.83  0.12, p¼0.021) as
well as a non-signiﬁcant increase in CFR (2.5  1.1 vs 2.2  0.87, p¼0.170).
Conclusions: The modiﬁcation of systemic BP during IV-Ado is related to the
hyperemic microcirculatory resistance in the heart. Profound ado-induced hypotension
is associated with obesity, lower coronary microcirculatory resistance, and lower FFR
values.acts/POSTER/Physiologic Lesion Assessment B191
